Swiss startup Aeon, focused on preventive health, secures €8.2M in seed funding round led by London-based VC Concentric.
Funds will be used for expanding across Switzerland, Germany, and the UK, improving AI platform, and building partnerships with insurers and employers.
Aeon offers AI-powered check-ups combining whole-body MRI, blood biomarker analysis, and genetic testing to detect over 500 diseases early with a 0% false positive rate.
The company aims to redefine preventive care by providing proactive, personalized health management and has already signed deals with Switzerland's largest insurance providers.